Team:Yale/Notebook
From 2014.igem.org
Line 124: | Line 124: | ||
<div class = "callout"> | <div class = "callout"> | ||
- | <h1 style="margin-top:70px; font-size:50px;"><FONT COLOR="#00B585"> | + | <h1 style="margin-top:70px; font-size:50px;"><FONT COLOR="#00B585">Lab Notebook</h1> |
</div> | </div> | ||
Revision as of 03:20, 15 October 2014
Lab Notebook |
|||||||||||
The ProblemThe Problem: | |||||||||||
Our SolutionThe Solution: To address this issue, we aimed to develop an anti-microbial peptide composed of two components, which we envision can be modulated to suit a variety of functional adhesive applications. The ideal anti-microbial peptide coating would exhibit both biofilm-inhibitory activity as well as strong adhesion to a variety of substrates. In addition, we sought to identify a biomimetic adhesive domain so as to enhance the environmental friendliness of our peptide. Mussel adhesive proteins (MAPs), which are secreted by the mussel to help it anchor and survive in the harsh conditions of the intertidal zone, are an effective and environmentally sound adhesive domain. As our anti-microbial domain, we selected LL-37, a member of the cathelicidin family of peptides, due to the potency of its toroidal pore mechanism of lipid bilayer disruption. MAPs selectively attach to inorganic and organic surfaces via L-dopamine (L-DOPA), which is generated by post-translational modification of tyrosine with tyrosinase (often secreted along with the MAPs by the mussels in an enzyme cocktail that assists with the crosslinking of MAPs). Our study sought to be the first to synthesize an entire recombinant anti-microbial adhesive peptide without the need for post-translational modifications. We incorporated L-DOPA, a nonstandard amino acid, into our construct using a genetically recoded organism (GRO). Because this peptide is toxic to the GRO in which it is produced, we designed a better controlled inducible system that limits basal expression. This was achieved through a novel T7 riboregulation system that controls expression at both the transcriptional and translational levels. This improved system is a precise synthetic switch for the expression of cytotoxic substances in the already robust T7 system. Lastly, a variety of tests were carried out to characterize our recombinant protein in comparison to the commercially available MAP-based adhesive, Cell-TakTM. |
|||||||||||
Project Goals
1. Create a T7 Riboregulation System to control the expression of our proteins:
2. Design the anti-biofouling peptide using both a modular approach:
3. Develop an erosion rig to assess the strength of the adhesive peptide:
|